Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?
- PMID: 10468034
- DOI: 10.1023/a:1014818118224
Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?
Abstract
Purpose: The aim of this work was to understand the mechanism by which co-encapsulated PEG 400 improved the stability of NGF and allowed a continuous release from PLGA 37.5/25 microspheres.
Methods: Microparticles were prepared according to the double emulsion method. PEG 400 was added with NGF in the internal aqueous phase (PEG/PLGA ratio 1/1 and 1.8/1). Its effect was investigated through interfacial tension studies. Protein stability was assessed by ELISA.
Results: A novel application of PEG in protein stabilization during encapsulation was evidenced by adsorption kinetics studies. PEG 400 limited the penetration of NGF in the interfacial film of the primary emulsion. Consequently, it stabilized the NGF by reducing the contact with the organic phase. In addition, it avoided the NGF release profile to level off by limiting the irreversible NGF anchorage in the polymer layers. On the other hand, the amount of active NGF released in the early stages was increased. During microparticle preparation, NaCl could be added in the external aqueous phase to modify the structure of microparticles. This allowed to reduce the initial release rate without affecting the protein stability always encountered in the absence of PEG.
Conclusions: PEG 400 appeared of major interest to achieve a continuous delivery of NGF over seven weeks from biodegradable microparticles prepared by the double emulsion technique.
Similar articles
-
NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.J Control Release. 1998 Dec 4;56(1-3):175-87. doi: 10.1016/s0168-3659(98)00086-8. J Control Release. 1998. PMID: 9801441
-
Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.J Control Release. 2005 Dec 5;109(1-3):86-100. doi: 10.1016/j.jconrel.2005.09.016. Epub 2005 Nov 2. J Control Release. 2005. PMID: 16266769
-
Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.Pharm Res. 2004 Feb;21(2):339-43. doi: 10.1023/b:pham.0000016248.30579.2f. Pharm Res. 2004. PMID: 15032317
-
PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.Int J Pharm. 2003 Aug 11;261(1-2):69-80. doi: 10.1016/s0378-5173(03)00272-2. Int J Pharm. 2003. PMID: 12878396
-
Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.Yao Xue Xue Bao. 2007 Jan;42(1):1-7. Yao Xue Xue Bao. 2007. PMID: 17520799 Review.
Cited by
-
Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF.Pharm Res. 2010 Jan;27(1):82-91. doi: 10.1007/s11095-009-0009-x. Epub 2009 Nov 17. Pharm Res. 2010. PMID: 19921405
-
Adsorption and Structuration of PEG Thin Films: Influence of the Substrate Chemistry.Polymers (Basel). 2024 Apr 29;16(9):1244. doi: 10.3390/polym16091244. Polymers (Basel). 2024. PMID: 38732713 Free PMC article.
-
Lysozyme stability in primary emulsion for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients.Pharm Res. 2002 May;19(5):629-33. doi: 10.1023/a:1015354028908. Pharm Res. 2002. PMID: 12069165
-
Protein instability in poly(lactic-co-glycolic acid) microparticles.Pharm Res. 2000 Oct;17(10):1159-67. doi: 10.1023/a:1026498209874. Pharm Res. 2000. PMID: 11145219 Review.
-
Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin at aqueous/organic interface.Mol Pharm. 2007 Jul-Aug;4(4):561-70. doi: 10.1021/mp060120z. Epub 2007 Apr 18. Mol Pharm. 2007. PMID: 17439239 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources